Structure-activity studies on 2-methyl-3-(2(S)- pyrrolidinylmethoxy)pyridine (ABT-089): An orally bioavailable 3-pyridyl ether nicotinic acetylcholine receptor ligand with cognition-enhancing properties

Nan Horng Lin, David E. Gunn, Keith B. Ryther, David S. Garvey, Diana L. Donnelly-Roberts, Michael W. Decker, Jorge D. Brioni, Michael J. Buckley, A. David Rodrigues, Kennan G. Marsh, David J. Anderson, Jerry J. Buccafusco, Mark A. Prendergast, James P. Sullivan, Michael Williams, Stephen P. Arneric, Mark W. Holladay

Research output: Contribution to journalArticlepeer-review

63 Scopus citations

Fingerprint

Dive into the research topics of 'Structure-activity studies on 2-methyl-3-(2(S)- pyrrolidinylmethoxy)pyridine (ABT-089): An orally bioavailable 3-pyridyl ether nicotinic acetylcholine receptor ligand with cognition-enhancing properties'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemistry